Inimmune Corporation
Clinical trials sponsored by Inimmune Corporation, explained in plain language.
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage trial tested a new nasal spray called INI-2004 in 68 healthy volunteers and people with ragweed allergies. The main goal was to check safety and find the right dose. Researchers monitored side effects, vital signs, and nasal symptoms after single and multiple dos…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated May 26, 2026 08:58 UTC
-
New nasal spray shows promise for ragweed sufferers
Symptom relief CompletedThis study tested an experimental nasal spray called INI-2004 in 78 adults with ragweed allergies. Participants received either the spray or a placebo once a week for 4 weeks. The goal was to see if the spray safely reduces nasal symptoms like sneezing and congestion when exposed…
Phase: PHASE2 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC